DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

March 29, 2024

ACT NOW: Comment Publicly to Support Coverage of Brain Cancer Treatment in WA State

EBCI logo white

The Washington State Health Care Authority (HCA) has denied coverage for Optune Gio/Tumor Treating Fields, preventing 2.5 million Washington Medicaid patients and public employees from accessing this innovative therapy. The public comment period is NOW OPEN. Comments can be submitted until 5pm PT on April 3, 2024 to this email address: shtap@hca.wa.gov.

Below are instructions for submitting your public comment to advocate for cancer patients in Washington State. If you would like to write your comment on EBCI letterhead, you can download it here.

To: shtap@hca.wa.gov

Subject Line: Include the words “To Request a Re-Review of the Optune Gio/TTF Device for Coverage”

First Paragraph: State why there should be coverage and what the option to have this treatment would mean to the general public, brain tumor/brain cancer and cancer community. Include the words: “To Request a Re-Review of the Optune Gio/TTF Device for Coverage.”

Second Paragraph: Briefly describe your story/loved one’s story, why you care, and why you are taking the time to issue this public comment requesting the re-review.

Additionally: Be sure to include your contact information.
Attach your comment to your email as a PDF, as well as including it in the body of your email.

For an example, read the comment from EBCI President & CEO Dellann Elliott Mydland below. It is best to NOT copy her comment exactly, as your comment may be weeded out if it is too similar.

For questions about the public comment process or for technical assistance, please contact EBCI Clinical Research Coordinator & Patient Navigator Shreya Prakash at Shreya@EndBrainCancer.org or 425-436-8688.

Glioblastoma is terminal, and the options for patients with this devastating cancer are limited. Patients need as many tools in their toolbox as possible to treat this disease. A treatment that has been approved by the FDA should be accessible for patients no matter their income level, what state they live in, or who their employers are. We know that creating a groundswell of support can help encourage decision makers to act.


Shreya Prakash photo
Shreya Prakash

Shreya Prakash
Clinical Research Coordinator
& Patient Navigator
shreya@endbraincancer.org

425-436-8688

contact QR code

Scan or click QR code to reach EBCI's Clinical Research Coordinator.

Sponsor logos

Hand holding cell phone displaying app

MORE Calls to Action and Advocacy Opportunities on the

EBCI App QR

Scan or click the QR code to download the App now!


ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram